TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
SVRA

Savara Inc

Healthcare · Biotechnology

5.40$ +5.7% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns Savara Inc (SVRA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 63.2% of the shares are freely tradable; institutional investors hold 104.2%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 104.2%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 2.6%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 63.2%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 23.6%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 206Mio.

Largest Shareholders

Institutions

Institutions SVRA
Name Stake (%) Shares Change (%) Date
NEA Management Company, LLC 11.91 24,471,264 +0.0 03/31/2026
Bain Capital Life Sciences Investors, LLC 8.57 17,600,621 +0.0 03/31/2026
VR Adviser, LLC 6.69 13,740,375 +0.0 03/31/2026
Deerfield Management Co 6.60 13,569,000 +0.0 03/31/2026
TCG Crossover Management, LLC 6.02 12,362,205 +0.0 06/30/2026
BlackRock Inc 5.50 11,291,185 +1.7 03/31/2026
Frazier Life Sciences Management, L.P. 4.73 9,720,852 -1.4 03/31/2026
Polar Capital Holdings PLC 4.64 9,541,786 +14.9 03/31/2026
Vanguard Capital Management, LLC 3.79 7,783,913 +0.0 03/31/2026

Funds

Funds SVRA
Name Stake (%) Shares Change (%) Date
Polar Capital Healthcare Opports Inc 3.99 8,191,216 +0.0 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?